This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Human Gene Mutation Database | |
|---|---|
| Name | Human Gene Mutation Database |
| Type | Genetic mutation repository |
| Established | 1996 |
| Owner | Institute of Medical Genetics at Cardiff University (original) |
| Country | United Kingdom |
| Access | Subscription and limited public access |
Human Gene Mutation Database
The Human Gene Mutation Database is a curated repository cataloguing germline mutations in nuclear, mitochondrial, and other human genes associated with inherited disease. It serves clinicians, geneticists, molecular biologists, and policy-makers by aggregating variant descriptions, gene-centric summaries, and literature citations for diagnostic, research, and epidemiological purposes. Major collaborations and citations link this resource to institutions and projects worldwide in clinical genomics and medical genetics.
The database compiles reported pathogenic and likely pathogenic variants from primary literature, diagnostic laboratories, and locus-specific databases to provide a centralized mutation catalogue used in Human Genome Project follow-on initiatives, 1000 Genomes Project comparative analyses, and translational efforts such as Clinical Genome Resource. It cross-references nomenclature standards from bodies like Human Genome Organisation and leverages work from consortia including Exome Aggregation Consortium, Genome Aggregation Database, and national initiatives such as Genomics England and All of Us Research Program. The resource is cited by journals including Nature Genetics, American Journal of Human Genetics, and The Lancet in studies of monogenic disease incidence and variant pathogenicity.
Founded in the mid-1990s at an academic centre with expertise in medical genetics, the database evolved alongside landmark endeavours like the Human Genome Project and the establishment of sequence databases at institutions such as the European Bioinformatics Institute and National Center for Biotechnology Information. Key milestones parallel developments at regulatory and professional organizations including World Health Organization, American College of Medical Genetics and Genomics, and Human Variome Project. As sequencing throughput expanded with technologies developed by firms like Illumina and Roche Diagnostics, the database scaled curation processes and integrated standards from groups including International Committee on Taxonomy of Viruses-like nomenclature efforts for genetic variants. Funding and publication interactions involved agencies such as Medical Research Council (United Kingdom), Wellcome Trust, and national health services exemplified by NHS England.
Entries describe variant type, molecular consequence, gene locus, and associated phenotypes, often citing case reports from investigators affiliated with institutions like Johns Hopkins University, Massachusetts General Hospital, Mayo Clinic, and universities such as Oxford University and Cambridge University. The collection includes variants in genes implicated in disorders documented in resources like Online Mendelian Inheritance in Man and diagnostic panels used at centres such as Great Ormond Street Hospital and St. Jude Children's Research Hospital. It spans single-nucleotide changes, small insertions/deletions, splicing defects, and larger rearrangements reported in literature from journals including Science, Cell, and Genome Research.
Access is principally subscription-based with tiered licensing for universities, clinical laboratories, pharmaceutical companies, and governmental agencies, paralleling licensing models seen at repositories such as UniProt and ClinVar (for contrast). Commercial users and translational programmes engaged with regulatory authorities like European Medicines Agency and Food and Drug Administration often secure institutional subscriptions. Limited free access or summaries may be provided for educational bodies including University College London and public health initiatives coordinated by agencies such as Centers for Disease Control and Prevention.
Curation follows expert review workflows similar to practices at ClinVar submitter review panels and leverages variant nomenclature standards from Human Genome Organisation and variant classification guidelines from American College of Medical Genetics and Genomics. Quality control includes cross-checking against sequence repositories at GenBank, allele frequency comparisons with gnomAD data, and literature verification referencing publications in New England Journal of Medicine and specialty journals in medical genetics. Expert curators often collaborate with clinical laboratories at institutions like Karolinska Institutet and University of Tokyo to resolve conflicting reports and to update pathogenicity designations.
Researchers use the database to prioritize candidate variants in studies tied to consortia such as International HapMap Project and disease networks like the Cancer Genome Atlas when distinguishing somatic from germline events. Clinicians and diagnostic laboratories integrate entries into variant interpretation pipelines alongside guidelines from organizations like European Society of Human Genetics and American Society of Human Genetics. Pharmaceutical and biotechnology firms reference the resource during target validation and rare disease drug development efforts in collaborations with entities such as Pfizer, Roche, and startup incubators associated with Wellcome Trust.
Critiques focus on subscription access models that contrast with open-data movements championed by Open Genome Project-style advocates and public repositories like ClinVar, raising concerns among academic institutions including Max Planck Society and advocacy groups such as Genetic Alliance. Additional limitations include potential publication bias from over-representation of data from high-income countries and major centres (for example, many reports originate from institutions like Harvard Medical School and Stanford University), variable depth of phenotype annotation compared with phenotype ontologies developed by Human Phenotype Ontology collaborators, and challenges reconciling historical nomenclature with modern standards promoted by bodies like International Committee on Medical Journal Editors.
Category:Genetics databases